Filter

Refine by Subjects

Refine by Access

Refine by Type

Refine by Date

—
  • Print
  • Save

Search Results

You are looking at 51 - 60 of 198 items for

  • Author or Editor: Elham Amiri x
  • All content x
Clear All Modify Search
Restricted access

Hydrocortisone Suspension 2 mg/mL*

Edited by Rita K. Jew, Winson Soo-Hoo, Sarah C. Erush, and Elham Amiri

Chapter

Cover Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

In  Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

Published (Print):
May 2016
Restricted access

Nifedipine Suspension 1 mg/mL

Edited by Rita K. Jew, Winson Soo-Hoo, Sarah C. Erush, and Elham Amiri

Chapter

Cover Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

In  Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

Published (Print):
May 2016
Restricted access

Rifabutin Suspension 20 mg/mL*

Edited by Rita K. Jew, Winson Soo-Hoo, Sarah C. Erush, and Elham Amiri

Chapter

Cover Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

In  Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

Published (Print):
May 2016
Restricted access

Baclofen Suspension 10 mg/mL

Edited by Rita K. Jew, Winson Soo-Hoo, Sarah C. Erush, and Elham Amiri

Chapter

Cover Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

In  Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

Published (Print):
May 2016
Restricted access

Ondansetron Suspension 0.8 mg/mL

Edited by Rita K. Jew, Winson Soo-Hoo, Sarah C. Erush, and Elham Amiri

Chapter

Cover Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

In  Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

Published (Print):
May 2016
Restricted access

Olmesartan Suspension 2 mg/mL

Edited by Rita K. Jew, Winson Soo-Hoo, Sarah C. Erush, and Elham Amiri

Chapter

Cover Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

In  Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

Published (Print):
May 2016
Restricted access

Losartan Suspension 2.5 mg/mL*

Edited by Rita K. Jew, Winson Soo-Hoo, Sarah C. Erush, and Elham Amiri

Chapter

Cover Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

In  Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

Published (Print):
May 2016
Restricted access

Valganciclovir Suspension 60 mg/mL

Edited by Rita K. Jew, Winson Soo-Hoo, Sarah C. Erush, and Elham Amiri

Chapter

Cover Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

In  Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

Published (Print):
May 2016
Restricted access

Atenolol Syrup 2 mg/mL—Formulation 1*

Edited by Rita K. Jew, Winson Soo-Hoo, Sarah C. Erush, and Elham Amiri

Chapter

Cover Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

In  Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

Published (Print):
May 2016
Restricted access

Pyrimethamine Suspension 2 mg/mL*

Edited by Rita K. Jew, Winson Soo-Hoo, Sarah C. Erush, and Elham Amiri

Chapter

Cover Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

In  Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients

Published (Print):
May 2016